Clinical Trials Logo

Protein clinical trials

View clinical trials related to Protein.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06267235 Completed - Healthy Clinical Trials

Dietary Protein Restriction and Health

LOWPRO
Start date: May 1, 2018
Phase: N/A
Study type: Interventional

The incidence of type 2 diabetes worldwide has increased significantly over the past decades, which is associated with changing dietary habits and physical inactivity. According to the diet, so far there has been a great focus on the quality of carbohydrates and fat in relation to metabolic health, while the importance of protein has been neglected. The Danes' average protein intake is 1.5 g/kg/day, which is at the high end of the recommendations (0.8-1.5 g/kg/day) from the Nordic Nutrition Recommendations (NNR 2023). Recent studies in rodents have shown that protein restriction has positive effects on health, including improved glucose and insulin homeostasis and reduced fat mass, while a high intake of protein has a negative effect on insulin sensitivity. Previously the investigators have shown, in healthy young men, that consuming a diet low in protein (0.9 g/kg/day), compared to the participants usual diet (1.5 g/kg/day), over 7 days, resulted in an increased insulin sensitivity as well as a marked increase in the plasma fibroblast growth factor 21 (FGF21) concentration. The increased insulin sensitivity is thought to be mediated by the increase in plasma FGF21 concentration. However, the effect is not yet fully understood. It is also not clear whether the increase in plasma FGF21 concentration, as well as the mentioned metabolic effects on insulin and glucose homeostasis, will take place if the participants are kept weight stable on a eucaloric diet.

NCT ID: NCT05368311 Completed - Obesity Clinical Trials

Effect of a Protein Intake on Weight Loss of Overweight/Obese Adults

COLABOCO
Start date: January 13, 2022
Phase: N/A
Study type: Interventional

Obesity is considered the epidemic of the 21st century. Obesity is a multifactorial disease and the most important risk factors are poor diet and sedentary lifestyle. An excessive body weight contributes to increase the risk of suffering from other diseases and mortality rates. Therefore, the prevention and control of excessive body weight as well as its comorbidities are essential. In this sense, the principal strategy to treat obesity is to improve dietary habits and increase physical activity. However, the rate of obesity continues rising. In order to deal with this problem, new strategies to combat obesity are being investigated, such as the investigation of new bioactive compounds with satiating capacity that can be included in healthy dietary patterns to improve adherence to dietary treatments. Considering this background, the main objective of this research is to assess the effect of daily consumption of protein rich bars accompanied by healthy dietary recommendations on weight loss of overweight/obese adult men and women.

NCT ID: NCT04468503 Completed - Critical Illness Clinical Trials

Comparative Effect of Protein Prescription Strategies on Nitrogen Balance and Upshots in Critically Ill Patients

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

This is Interventional clinical trail will be conducted in Internationale hospital ICU s patients with higher nutrition risk. two doses of protein 1 g/kg/day Vs 2 g/ kg day will be given and its outcome will be checked on nitrogen balance , clinical outcome length of hospital stay, mortality ratio and re admission within 30 days.

NCT ID: NCT04356573 Completed - Metabolism Clinical Trials

(KIWI) Speeding up a Slow Protein for Muscle Mass With Hay Kiwifruit

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The specific hypothesis is that the consumption of 2 Hayward green kiwifruit (containing actinidin protease) prior to 100g of ground beef will increase the rate of protein digestion from the beef in the elderly, leading to an increased uptake of the essential amino acids. Furthermore, this increased essential amino acid availability will produce a greater postprandial net anabolic protein response, as well as increased fractional synthetic rates of muscle proteins.

NCT ID: NCT03816579 Completed - Diet Clinical Trials

A Meal-based Comparison of Protein Quality, Complementary Proteins and Muscle Anabolism

MAPP
Start date: March 26, 2019
Phase: N/A
Study type: Interventional

To highlight the importance of protein quality rather than the total protein content of a meal, the investigators will demonstrate that unlike high quality proteins, a single meal containing 30 g of an incomplete protein source does not stimulate skeletal muscle protein synthesis. Secondly, the investigators will directly challenge a prevalent, but untested, assertion that has the potential to negatively impact health. The goal is to demonstrate that complementary plant-proteins (i.e., two or more incomplete protein sources) must be consumed at the same meal to stimulate protein synthesis.

NCT ID: NCT03561337 Completed - Nutrition Clinical Trials

Nutrient Supplementation Influences Mitochondria Adaptation

Start date: October 1, 2013
Phase: N/A
Study type: Interventional

Twenty-four well trained runners (VO2max 60.73.7 ml O2 Kg-1 min1) completed a six week block randomized controlled intervention period. Subjects were randomly assigned to either PRO-CHO or CHO and matched in pairs for gender, age, VO2max, training and performance status. The PRO- CHO group ingested a protein beverage (0.3g kg-1) before and protein-carbohydrate beverage (0.3g protein kg-1 and 0.1g carbohydrate kg-1) after each exercise session. The CHO group ingested energy matched carbohydrate. Post-absorptive muscle biopsies were obtained pre and post intervention for analysis HAD, CS and PGC-1. Subjects completed two physical tests 6 km performance test (pre, week 1 and week 6) and aVo2max test (pre and post intervention).

NCT ID: NCT03409380 Completed - Protein Clinical Trials

Supplementation Trial on Arginine With Metabolic Profiling

STAMP
Start date: February 8, 2018
Phase: N/A
Study type: Interventional

This study will assess effects of an acute dose of the amino acid arginine on metabolism in healthy young men.

NCT ID: NCT03115775 Completed - Protein Clinical Trials

CLA and Vitamin D on Protein Turnover

TM
Start date: May 12, 2017
Phase: N/A
Study type: Interventional

To conduct a randomized, double-blind, controlled clinical trial to determine the independent and combined effects of dietary conjugated linoleic acid (CLA) and vitamin D supplementation on anabolic signaling, the expression of growth regulatory factors, and muscle protein turnover in older adults.